Evidence map›Paper›PMID 35153765›Full record

ArticleFrontiers in pharmacology2021

Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants.

Man Yang, Bin Xia, Yawen Lu, Qiangsheng He, Yanyan Lin, Ping Yue, Bing Bai, Chunlu Dong, Wenbo Meng, Jian Qi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Role ofWorld journal of gastroenterology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Man YangThe First Clinical Medical School of Lanzhou University, Lanzhou, China.
Bin XiaClinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Yawen LuThe First Clinical Medical School of Lanzhou University, Lanzhou, China.
Qiangsheng HeClinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Yanyan LinThe First Clinical Medical School of Lanzhou University, Lanzhou, China.
Ping YueThe Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Bing BaiThe Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Chunlu DongThe Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Wenbo MengThe First Clinical Medical School of Lanzhou University, Lanzhou, China.
Jian QiGuangdong Provincial Key Laboratory of Gastrointestinal Cancers, Center for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Jinqiu YuanGuangdong Provincial Key Laboratory of Gastrointestinal Cancers, Center for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Lanzhou University · CNFirst Hospital of Lanzhou University · CNSun Yat-sen University · CNThe Seventh Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

choletithiasiscohort studyH2-receptor antagonistsproton pump inhibitorrisk factor

Identifiers

PMID35153765
PMCPMC8831324
OpenAlexW4210453100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.